Gary Pasternack was former Director of the Division of Molecular Pathology and of the Graduate Program in Pathobiology at the Johns Hopkins University School of Medicine. He received his undergraduate, MD, and PhD degrees from Johns Hopkins and did his residency and fellowship training at Yale.

Dr. Pasternack has been a principal in a number of biotechnology businesses, was an inventor on over ten issued U.S. patents, and consulted actively in the biotechnology, pharmaceutical, and financial communities.

Dr. Pasternack served as the CEO of Asklepion Pharmaceuticals, LLC., a biopharmaceutical company based in Baltimore, Maryland.